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Abstract
Herpesviruses are large, ubiquitous DNA viruses with complex host interactions, yet many of the proteins encoded by these
viruses have not been functionally characterized. As a first step in functional characterization, we determined the subcellular
localization of 234 epitope-tagged proteins from herpes simplex virus, cytomegalovirus, and Epstein–Barr virus. Twenty-four
of the 93 proteins with nuclear localization formed subnuclear structures. Twelve of these localized to the nucleolus, and
five at least partially localized with promyelocytic leukemia (PML) bodies, which are known to suppress viral lytic infection.
In addition, two proteins disrupted Cajal bodies, and 19 of the nuclear proteins significantly decreased the number of PML
bodies per cell, including six that were shown to be SUMO-modified. These results have provided the first functional insights
into over 120 previously unstudied proteins and suggest that herpesviruses employ multiple strategies for manipulating
nuclear bodies that control key cellular processes.
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Introduction
Herpesviruses are large DNA viruses that each encode between
80 and .200 proteins. This complex network of proteins results in
a variety of effects on the host cell and ensures efficient
proliferation of the virus. While the functions of a subset of these
proteins are reasonably well understood, there is little or nothing
known about the function of many of the proteins. Understanding
the role that each viral protein plays is not only useful for
determining how the virus propagates and potentially inhibiting
that propagation, but also for identifying mechanisms that regulate
key cellular processes.
Herpesviruses are divided into alpha, beta and gamma
subfamilies, which differ considerably in their modes of latent
infections and in their effects on the host cells. These studies
involve one member of each of the three subfamilies of
herpesviruses; herpes simplex type 1 (HSV-1) of the alphaherpes-
viruses, human cytomegalovirus (CMV) of the betaherpesviruses
and Epstein-Barr virus (EBV) of the gammaherpesviruses. All
three of these viruses can cause significant human disease in
addition to providing interesting model systems for viral-host
interactions. HSV-1 and EBV encode 80–85 proteins, while the
larger CMV encodes approximately 200–230 proteins (depending
on the strain). Beyond a set of core genes found in all
herpesviruses, the remaining genes are specific to either the
subfamily or individual virus and likely contribute to their
individual and complex replication strategies. The high number
of CMV proteins relative to those of HSV and EBV clearly reflects
aspects of CMV infection that must be unique to this virus or
subfamily, and many of these proteins have no assigned function;
in fact, over 60% of the CMV-encoded proteins have no
functional annotation. A better understanding of the individual
protein functions would be useful for a more mechanistic
understanding of the commonalities and differences in these three
viruses.
Determination of subcellular localization is one way that the
potential roles of large numbers of proteins can be assessed [1].
Such global screening of subcellular localization has been
successfully conducted with yeast and human proteins, where
individual proteins were expressed fused to epitope or to GFP tags
[2–4]. For most proteins, localization results were found to be
consistent in different studies regardless of the tag used or
expression level. Subcellular localization screening is also an
appropriate starting point for the characterization of herpesvirus
proteins, providing insight into the potential contribution of the
protein to viral infection as well as the cellular processes that may
be manipulated. Although the localization is known for the
majority of HSV proteins, the localization is known for only about
50% of the EBV proteins and 10% of CMV proteins, leaving over
200 proteins from these 3 viruses that are uncharacterized.
Successful herpesvirus infections require manipulation of the host
cell processes to favor viral infection, including alterations of host
nuclear bodies (NBs). Indeed many RNA and DNA viruses are
known to target various host NBs as part of their replication
strategies. For example, adenoviruses and herpesviruses encode
several proteins that cause redistribution of nucleolar components,
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function, including disrupting rRNA synthesis, processing and
trafficking [5,6]. Cajal bodies, which are important for the
maturation of nuclear RNP complexes, are site of localization of
theavianherpesvirusMDVMeqprotein[7]and arereorganizedby
adenovirus infection [8,9] and by groundnut rosette virus ORF3
[10]. A few herpesvirus proteins have been reported to associate
with nuclear speckles (also called SC35 domains or splicing
speckles), nuclear structures that are storage sites for splicing factors
and, in some cases, alter nuclear speckles as a reflection of their
effects on cellular transcription and splicing [11–16].
Perhaps the most notable NB affected by viral infection are
promyelocytic leukemia (PML) bodies (also called ND10s or
PODs). PML NBs are involved in several important host cell
processes including apoptosis and the DNA damage response [17].
In addition, they suppress lytic infection of both RNA and DNA
viruses as part of an intrinsic immune response and may also
regulate quiescent viral infections [18–22]. For example, overex-
pression of a PML isoform has been shown to inhibit the
replication of Human Foamy Virus, Vesicular Stomatitis Virus
(VSV) and influenza virus, while silencing of PML enhances the
propagation of influenza virus and CMV [18,21,22]. Also PML-
deficient mice are more susceptible to VSV, rabies virus and
lymphocytic choriomeningitis virus infections [23–25]. To coun-
teract this antiviral response, some viral proteins disrupt PML
NBs, often through degradation or dispersal of the PML protein
that forms the core of PML NBs [15,16,26]. For herpesviruses,
HSV ICP0, CMV IE1 and EBV BZLF1 proteins have been found
to disrupt PML bodies through effects on the PML protein, and
this effect of ICP0 and IE1 has been shown to correlate with
increased lytic viral expression and replication [22,27–31]. While a
small number of herpesvirus proteins have been identified that
contribute to viral infection through alteration of host NBs, many
proteins have never been examined for these effects.
To gain a more comprehensive understanding of the many
functions of herpesvirus proteins, we have generated a mammalian
expression library consisting of most of the open reading frames of
HSV, CMV and EBV. These proteins are expressed fused to a C-
terminal tag suitable for protein localization and protein
interaction studies. We present the subcellular localization
screening for all of these proteins. We also identify viral proteins
that localize to and/or alter host NBs, including several that had
not previously been characterized.
Results
Expression libraries
In order to conduct genome-wide studies on herpesvirus
proteins, we attempted to clone each of the predicted ORFs from
HSV-1, CMV (strain AD169) and EBV into a mammalian
expression vector from which proteins are expressed fused to a C-
terminal sequential purification affinity (SPA) tag comprised of a
calmodulin binding peptide and a triple FLAG epitope [32]. Such
constructs are suitable for both protein localization and protein
interactions studies. In addition, nineteen CMV ORFs (UL133-
151) not present in the AD169 laboratory strain were cloned from
the Towne strain of CMV. While not every potential ORF was
recovered in the high throughput cloning effort, we generated
expression constructs for the majority of each genome namely, 60
HSV, 61 EBV, 148 CMV ORFs. A comprehensive list of the
individual proteins used in this study is provided as Table S1. We
examined the migration of approximately half of the viral proteins
in Western blots to verify the quality of the expression library and
found that 91% (103 out of 113) migrated at the predicted size or
larger (see sample blots in Figure S1), with the remaining 9% ran
faster than expected (perhaps due to protein truncation, proteolysis
or anomalous migration). Note that anomalously slow migration in
SDS-PAGE is a common property of highly charged proteins and
is consistent with the highly basic or acidic nature of most of the
viral proteins that we found to migrate slower than their predict
molecular weight.
Subcellular localization of herpesvirus proteins
We attempted to determine the subcellular localization for all of
the viral proteins expressed in 293T cells, by transient transfection
of the expression plasmids and immunofluorescence (IF) micros-
copy for the FLAG epitope (Figure 1A). We obtained localization
data for 234 proteins from the 269 expression plasmids tested, of
which 148 (14 HSV, 100 CMV, 34 EBV) have not been previously
characterized in terms of their localization and most of these also
lack any functional characterization. The localization of 35 of the
viral proteins could not be determined due to protein expression
below detectable levels and/or cell toxicity. Of the 234 viral
proteins we visualized, 85 have previously published subcellular
localization data, and there is excellent agreement between our
results and previous reports (see Table S1 for individual protein
results). Minor discrepancies in localization were observed for
about 15 proteins with only 2 proteins (1.3%; HSV UL56 and
EBV BRRF1) being exclusively in subcellular compartments
different from previous reports. To determine the likelihood of the
protein localization being altered due to our C-terminal tag, we
also compared our localizations to those in the literature for
individual proteins expressed without a tag. Twelve such proteins
(4 HSV and 8 CMV) were identified and all had localizations
consistent with ours (see Table S1). Some discrepancies would be
expected with localizations determined in the context of viral
infection since interactions between viral proteins can alter the
localization of the individual proteins. Therefore we also
compared our localization data to that determined for untagged
viral proteins in the context of viral infection. 24 of the HSV, 12
CMV and 9 EBV proteins in our study had been previously
localized in the context of an infection using specific antibodies.
Two of these proteins (HSV UL19 and UL56) had localizations
that were inconsistent with our observations, while seven more
(HSV ORFP, UL29, UL30, UL31, UL35, UL51, US12) had
Author Summary
Herpes simplex virus, Epstein–Barr virus, and cytomegalo-
virus are three types of human herpesviruses that infect
most people for their entire life and, under some
circumstances, cause significant diseases. Each virus
encodes a large number of proteins that function to
manipulate the host cell to the best advantage of the virus;
however, many of these encoded proteins have never
been studied. We have generated constructs to express
most of the proteins encoded by these three viruses in
human cells and have determined the precise localization
of each in the cell. We have also examined how each viral
protein affects host nuclear structures called PML bodies,
which are part of the cellular response to suppress viral
replication. We identified several proteins from all three
viruses that disrupt PML bodies, suggesting that they
would enable viral infection. Our study has given the first
information on the potential function of 120 previously
unstudied viral proteins and shows that each virus has
multiple mechanisms to disrupt PML bodies that were not
previously recognized.
Herpesvirus Protein Effects on PML Bodies
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than the patterns we observed (see Table S1). Differences in
localization could be due to the presence of additional viral
proteins during infection, differences in protein expression levels or
the presence of our epitope tag. As expected, this initial analysis
shows that such high through-put localization screening will not
accurately determine the localization of every viral protein in the
context of infection, however it does show that such an approach is
appropriate for predicting the localization of the vast majority of
viral proteins even in the context of infection.
Protein localizations were broadly categorized as either pan-
cellular, pan-cytoplasmic, subcytoplasmic, pan-nuclear or subnu-
clear. Some proteins had more complex localization patterns and
fell into multiple categories (e.g. HSV UL24 is subcytoplasmic and
subnuclear) and, in these instances, the protein was recorded in the
most prevalent category and the localization pattern detailed in
the notes section of Table S1. The results for all proteins are
summarized in Figure 1A and detailed in Table S1. Most of the
viral proteins were diffusely localized throughout the nucleoplasm
(52 proteins), throughout the cytoplasm (40 proteins) or through-
out both compartments, often at unequal levels (87 proteins). In
addition, 44 proteins localized to subcytoplasmic structures as
shown in Figure S2. Five proteins (CMV UL12, UL59, US3, US5
and HSV UL12), appeared as vesicular-like bodies throughout the
cytoplasm and seven proteins (HSV UL49, CMV UL77, UL135,
US27 and EBV BcRF1, BORF2, BXLF1) formed foci or plaques.
The remainder of the 44 subcytoplasmic proteins demonstrated
staining patterns indicative of organelle association similar to that
observed with the ER-localized protein disulphide isomerase
(PDI), and many co-localized with this marker indicating
association with the ER and/or secretory pathway (Table S1,
Figure S3). Finally, 14 of the viral proteins screened in 293T cells
localized to a variety of subnuclear structures with many adopting
a nucleolar-like appearance (Figure 1).
There are 26 proteins that are considered to be conserved across
all three families of herpesviruses [33], although in some cases the
degree of homology is limited. We have localization data for all of
the three homologues in HSV, CMV and EBV for six of these
protein families (Table S2). Not unexpectedly, the homologues
generally have the same subcellular localization with only two
proteins (CMV UL103 and HSV UL31) showing staining that was
slightly altered (but overlapping) with their homologues.
Subnuclear localizations
We are particularly interested in how herpesviruses manipulate
host nuclear events and therefore further characterized the viral
proteins that localized to the nucleus. Ninety-three proteins which
were completely (66) or predominantly (27) nuclear in 293T cells,
were reanalyzed in U2OS cells to verify their localization in
another cell background, free of endogenous viral proteins. Results
for individual proteins are indicated in Table S1. Eighty-three out
of the 93 proteins had localizations in U2OS cells that were
indistinguishable from those in 293T cells, including the 14
proteins found to be subnuclear in 293T cells (Figure 2, images
without asterisk). The remaining 10 proteins, recorded as pan-
nuclear or pan-cellular in 293T cells, also had the same
localization in most U2OS cells, but in a fraction of the U2OS
cells showed subnuclear localization (Figure 2, images with
asterisks). We have added these to the list of sub-nuclear proteins,
since they clearly have the capacity to form subnuclear structures
under some circumstances, perhaps at higher expression levels.
Two of the additional subnuclear proteins, HSV US1.5 and EBV
BKRF4, did not actually form nuclear bodies but rather exhibited
largely pan-nuclear staining with discreet foci that excluded the
viral protein (see Figure 2 and Figure S4).
In order to define the localization of the 24 subnuclear proteins
more precisely and to determine how these proteins affect nuclear
substructures, we analyzed the proteins by IF microscopy with
markers for four nuclear bodies (nucleoli, PML NBs, nuclear speckles
and Cajal bodies) that are targets of some viral proteins (Table 1).
Several of the proteins had a nucleolar-like localization and hence
were further examined for co-localization with EBP2 (EBNA-1
binding protein 2), a nucleolar protein involved in rRNA processing
[34,35]. Twelve of the 24 proteins tested co-localized with the EBP2
marker to varying degrees (Figure 3 and Table 1). Notably, CMV
US33 was almost exclusively localized to the nucleolus, whereas all
other proteins also demonstrated some nucleoplasmic localization. In
addition, three HSV proteins, RL1 (ICP34.5), US11 and UL24 also
showed significant cytoplasmic staining, including cytoplasmic
structures in the cases of US11 and UL24.
We also examined subnuclear proteins for localization to PML
NBs, Cajal NBs and nuclear speckles by co-staining for the main
constituents of these bodies, namely PML, coilin and SC35
proteins, respectively. Five of the 24 subnuclear proteins co-
localized at least partially with PML bodies (Table 1, Figure 4A).
CMV US32 showed the most striking co-localization with PML,
while CMV UL3 formed larger NBs that contained PML NBs and
Figure 1. Localization summary of herpesvirus proteins
expressed in 293T cells. (A) Summary table indicating the
localizations of herpesvirus proteins expressed in transfected 293T cells
as determined by IF detection of the C-terminal FLAG epitope. Viable
clones refers to the number of clones for which the viral protein was
detected by IF. (B) IF micrographs representative of the pan-cellular,
pan-cytoplasmic, subcytoplasmic, pan-nuclear and subnuclear localiza-
tions. Scale bar = 10 mm.
doi:10.1371/journal.ppat.1000100.g001
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CMV UL35 formed nuclear structures ranging from small round
foci to larger spherical nuclear and cytoplasmic structures in which
UL35 was excluded from the centre. PML co-localized with
smaller UL35 foci and was found at the periphery of the larger
spheres, following the contour of the structure. For EBV BKRF4,
10–20% of transfected cells exhibited diffuse nuclear staining with
multiple small foci from which BKRF4 was excluded. In these
cells, PML NBs were found at the periphery of these foci.
None of the 24 subnuclear proteins co-localized with Cajal
bodies or nuclear speckles (Table 1). The remaining seven
subnuclear proteins (HSV US1, US1.5, UL26.5, UL54 and
CMV UL30, UL69 and UL137) did not co-localize with any of the
host NBs that we examined, and the size and shape of these
structures tended to vary from cell to cell, depending on protein
expression levels.
Disruption of Cajal bodies
Although none of the 24 subnuclear proteins analyzed co-
localized with coilin at Cajal bodies in U2OS cells, we noticed a
tendency for cells expressing CMV UL3 or CMV UL30 to have
fewer or no coilin-positive bodies (Figure 5A). It should be noted
that, although both UL3 and UL30 can localize to sub-nuclear
bodies (Figure 2), in most of the cells the staining was pan-nuclear
as illustrated in Figure 5A. We saw no obvious correlation between
the presence or absence of subnuclear staining and the disruption
of Cajal bodies (data not shown). The observed decrease in Cajal
bodies was quantified by counting the number of Cajal bodies
observed by IF microscopy in U2OS cells expressing and not
expressing the viral protein. Untransfected U2OS cells contained
between 0 and 6 Cajal bodies per cell, with an average of 2.2 Cajal
bodies per cell, whereas cells expressing UL3 and UL30 had
significantly lower averages of 1.6 (p,0.05) and 1.2 (p,0.01) Cajal
bodies, respectively (Figure 5B). The effect of these proteins on the
number of Cajal bodies was even more apparent when the number
of cells with each of 0 to 6 Cajal bodies per cell was plotted
(Figure 5C). The expression of UL3 and UL30 resulted in a 2-fold
increase in the percentage of cells with no Cajal bodies and a
similar decrease in the percentage of cells with 4 to 6 Cajal bodies
per cell. These results indicate that CMV UL3 and CMV UL30
can cause the disruption and/or loss of Cajal bodies.
Figure 2. Herpesvirus proteins with subnuclear localization. U2OS cells transfected with expression plasmids for the indicated viral proteins
(green) were fixed and stained with FLAG antibody to visualize the viral protein. DNA was visualized with DAPI stain (blue). For proteins marked with
an asterisk (*), subnuclear structures were observed in U2OS cells but not in 293T cells while those not marked were observed in both U2OS and 293T
cells. Scale bar = 10 mm.
doi:10.1371/journal.ppat.1000100.g002
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We were particularly interested in examining the effects of viral
nuclear proteins on PML NBs, since some viral proteins are known
to stimulate lytic viral replication by disrupting PML NBs. As
mentioned above, five proteins at least partially co-localized with
PML NBs and three of these also noticeably altered the PML
bodies in various ways (Figure 4A). CMV US32 and UL3
expression resulted in PML NBs with altered size and shapes
relative to PML bodies in untransfected or vector-transfected cells
(compare to control panel in Figure 4B). In addition, in cells in
which CMV UL35 formed ring-shaped structures, PML was
reorganized into semi-circular structures corresponding to the
periphery of the viral protein donuts.
A small number of herpesvirus proteins are known to contribute
to lytic infection by decreasing the number of host PML NBs but
only a minority of the viral proteins have been tested for this
phenomenon. Given the important roles of PML NB in antiviral
defenses,apoptosisandotherprocesses,weexpandedouranalysisof
PML alterations beyond the 24 subnuclear proteins to include all 93
proteinswith nuclearlocalization.The effectoftheseproteinsonthe
size, shape and number of PML NBs was examined in U2OS cells
(Table S1). Sixty-one of the 93 nuclear proteins had no apparent
effect on PML NBs and only the three proteins mentioned above
appeared to reorganize the PML NBs. These results indicate that
most viral proteins with nuclear localization do not alter PML NBs
even at relatively high expression levels.
For any viral protein that was perceived to decrease or alter
PML NBs (35 proteins), the number of PML NBs per cell was
counted for 100 cells and compared to the same cells lacking viral
protein expression. Although the number of PML NBs varies from
cell to cell, untransfected U2OS cells contained an average of ,13
PML bodies per cell (Figure 4B and Figure 6A). Of the 35 viral
proteins for which PML NBs were counted, 16 decreased the
number of PML NBs by 20% or less with most of these 16 proteins
averaging between 11 and 14 PML bodies per cell. One of the
viral proteins in our study was EBV BZLF1 (also called Zta or
Zebra), which is known to disrupt PML bodies and was therefore
used as a positive control [29]. At low levels of protein expression,
BZLF1 had little effect on the number of PML bodies, however at
higher expression levels PML bodies were severely disrupted
(Figure 4B). On average, cells expressing various levels of BZLF1
had a modest yet significant (p,0.01) 21% decrease in the average
number of PML NBs (Figure 6A). Eighteen viral proteins, from all
three herpesvirus subfamilies, disrupted PML NBs to a greater
degree than BZLF1, causing a 23% to 57% decreases in the
average number of PML NBs per cell (Figure 6A) and examples of
these observed effects are shown in Figure 4B. Qualitatively, some
proteins appeared to require higher levels of protein expression
before effects on PML were observed (CMV UL69, UL76, UL98
and EBV BZLF1 and BFLF2). For all of the19 proteins that
significantly reduced the number of PML NBs, the size and shape
of the PML NBs was not obviously affected. The sizes of all of the
19 PML-disrupting proteins as well as the PML-altering proteins
in Figure 4A were verified by Western blotting (Figure S1).
PML body formation requires modification of PML by the small
ubiquitin-like modifier, SUMO [26,36], and SUMO-modified
proteins such as BZLF1can disrupt PML NBs by competing with
PML for limited cellular SUMO pools, resulting in inefficient
SUMOylation of PML [29]. Therefore we analyzed the 19
proteins that disrupted PML NBs for potential SUMOylation sites
using SUMOplot (www.abgent.com.cn/doc/sumoplot/). This
identified 8 proteins (EBV BZLF1, BRLF1, BDLF1, BFLF2 and
EBNA3B and CMV UL69, UL98 and US25) with at least one,
high-probability potential SUMO modification site (Table S3). We
tested whether these proteins were SUMOylated by co-expressing
them with myc-tagged SUMO-1 in U2OS cells then immuno-
precipitating the viral protein (Figure 6B). Consistent with previous
reports, BZLF1 and BRLF1 were SUMO-1 modified and
produced multiple higher molecular weight, SUMOylated forms
(Figure 6B; also see Figure S1 for protein migration in the absence
of exogenous SUMO). In addition, four other proteins (EBNA3B,
BFLF2, UL69 and US25) also showed various higher molecular
weight bands that reacted with the anti-myc antibody for SUMO-
1, indicating that they too are SUMO-1 modified. No SUMO-1
bands were evident for BDLF1 and CMV UL98 (Figure 6B,
bottom panel), although the low expression level of BDLF1 might
have hampered the detection of SUMO-modified forms.
Discussion
Herpesviruses are large DNA viruses with complex host
interactions but only a minority of the encoded proteins have
been functionally characterized. In order to gain insight into the
possible functions of the many uncharacterized herpesviral
proteins, we generated and screened genomic expression libraries
from HSV, EBV and CMV for subcellular localization, resulting
in the subcellular classification of 234 proteins. With only a few
exceptions, previously reported protein localizations were con-
firmed, while new localization data was generated for approxi-
mately 160 previously unlocalized proteins, most of which
Table 1. Subnuclear proteins and their association with host
nuclear bodies.
Nucleolus
Nuclear
Speckles PML Bodies Cajal Bodies
HSV RL1 Yes No No No
HSV US1 No No No No
HSV US1.5 No No No No
HSV US11 Yes No No No
HSV UL24 Yes No No No
HSV UL26.5 No No No No
HSV UL27.5 Yes No No No
HSV UL54 No No No No
CMV TLR5 Yes No No No
CMV TLR7 Yes No No No
CMV TLR9 Yes No No No
CMV US32 No No Yes No
CMV US33 Yes No No No
CMV UL3 No No Yes No
CMV UL29 Yes No No No
CMV UL30 No No No No
CMV UL31 Yes No No No
CMV UL35 No No Yes No
CMV UL69 No No No No
CMV UL76 Yes No No No
CMV UL80a No No Yes No
CMV UL108 Yes No No No
CMV UL137 No No No No
EBV BKRF4 No No Yes No
doi:10.1371/journal.ppat.1000100.t001
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study similar to ours was recently published for the human
gamma-herpesvirus HHV-8, which was found to have 51%
cytoplasmic and 22% nuclear proteins (with 27% in both
compartments) [37]. A comparison to our results with the other
human gamma-herpesvirus, EBV, suggests that EBV has a higher
proportion of nuclear proteins than HHV-8, with 31% in nuclear
and 31% in cytoplasmic compartments. We have focused our
attention on nuclear proteins for all three herpes viruses in our
study, including several proteins that localized to subnuclear
structures, in order to gain a more comprehensive understanding
of how herpesviruses alter host nuclear bodies to support viral
replication.
Many viruses encode proteins that interact with and/or alter the
nucleolus [38]. Traditionally described as the site of ribosome
biogenesis, the nucleolus is emerging as a multifunctional and
dynamic nuclear body that can contain hundreds of different
cellular proteins and is involved in several signaling pathways,
including cell cycle control [39,40]. Therefore, it is not surprising
that some herpesvirus proteins would alter nuclear process
through interactions with the nucleolus. Prior to this study, five
HSV proteins (ICP0, UL24, UL54, US11, RL1), one CMV
protein (UL76) and one EBV protein (EBNA5) were reported to
associate with the nucleolus, in some cases causing nucleolar
reorganization or redistribution of nucleolar components [41–45].
While ICP0 and EBNA5 were not included in our screen, we also
found that the remaining four proteins were associated with the
nucleolus, although to varying degrees. Although HSV UL24 and
CMV UL76 are related proteins, their localization was not
identical in our study. UL76 was almost exclusively located at the
nucleolus, whereas UL24 was observed in the nucleolus, the
nucleoplasm and in subcytoplasmic structures. UL24 has been
reported to disperse nucleolin from the nucleolus during HSV
infection [41], but we did not observe alterations in EBP2
Figure 3. Herpesvirus proteins associated with the nucleolus. U2OS cells expressing the indicated viral proteins were stained with FLAG
antibody to detect the viral protein (green) and with EBP2 antibody to visualize the nucleolus (red). Scale bar = 10 mm.
doi:10.1371/journal.ppat.1000100.g003
Herpesvirus Protein Effects on PML Bodies
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components or may require other HSV protein for nucleolar
remodeling. The former possibility is consistent with previous
observations that UL24 did not alter the nucleolar localization of
fibrillarin [41]. In addition to the differences in localization, UL76,
but not UL24, caused a significant decrease in the number of PML
NBs per cell. These differences would suggest that despite
sequence similarities, the functions of these two proteins may vary.
In addition to previously known nucleolar proteins, our screen
identified eight more proteins with nucleolar association; HSV
UL27.5 and CMV TRL-5, TRL-7, TRL-9, UL29, UL31, UL108
and US33. None of these proteins have been functionally
Figure 4. Effects of herpesvirus proteins on PML NBs. U2OS cells expressing the indicated viral proteins were stained with FLAG antibody to
detect the viral protein (green) and with PML antibody to visualize the PML protein (red). (A) Viral proteins that exhibit some degree of co-localization
with PML NBs. Images were also merged to show co-localization of viral proteins with PML bodies (yellow). (B) PML staining of untransfected control
cells and viral proteins that disrupt PML NBs. Scale bar = 10 mm.
doi:10.1371/journal.ppat.1000100.g004
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genes are known to moderately inhibit CMV infection [46]. Our
results suggest that these three proteins, as well as the remaining
nucleolar proteins may contribute to viral infectivity through
alteration of nucleolar functions.
None of the viral proteins in our screen co-localized with
nuclear speckles or Cajal bodies, however HSV US1 (more
commonly known as ICP22) was found to form small nuclear foci
that are juxtaposed and similar in number to nuclear speckles
(Figure S4). This pattern of pairing of ICP22 with nuclear speckles
has been previously reported [12]. In addition, the nuclear
speckles appeared to be remodeled in the presence of ICP22,
becoming more separated and punctate, rather than elongated
and interconnected (Figure S4). Since nuclear speckles are linked
to transcription and splicing, these observations may be connected
to the reported effects of ICP22 on cellular and viral gene
expression [47,48]. EBV BMLF1 (also called Mta) has also been
reported to be associated with nuclear speckles in transfected cells
[14], however this was not observed in our study possibly due to
the low expression level of this protein.
In the course of studying the subnuclear viral proteins, we found
that two previously uncharacterized CMV proteins, UL3 and
UL30, significantly decreased the number of Cajal bodies per cell.
UL3 and UL30 have little sequence similarity and vary
considerably in their contribution to CMV infection in fibroblasts;
UL3 is classified a non-essential gene, while deletion of UL30
caused a severe defect in viral replication [46]. The Meq protein
from the avian herpesvirus MDV has been reported to associate
with Cajal bodies [7], however, to our knowledge, CMV UL3 and
UL30 are the first human herpesvirus proteins reported to
associate with or disrupt these structures. Although the functions
of Cajal bodies are not completely clear, they are strongly
associated with transcription and the maturation of ribonuclear
particles and only form when these processes are active [49].
Therefore the disruption of Cajal bodies by UL3 and UL30 may
reflect inhibition of transcription or RNP formation.
There may also be a relationship between Cajal and PML NBs
in that these bodies have been reported to be juxtaposed and to
associate through the PIASy protein [50] . Therefore it may not be
a coincidence that we also found UL3 and UL30 to affect PML
NBs, albeit in different ways. UL3 formed NBs in about 20–30%
of the cells expressing this protein and, in these cells, PML NBs
were irregularly shaped and always associated with UL3 NBs,
suggesting remodeling of PML NBs by UL3. On the other hand,
UL3-expressing cells with pan-nuclear staining were unaffected in
the number or shape of PML NBs. In contrast, Cajal body
disruption was observed for US3-expressing cells that had either
pan-nuclear or NB localization, indicating that the mechanisms by
which UL3 affects Cajal and PML NBs differ and that Cajal body
disruption can occur in the absence of PML reorganization.
Unlike UL3, UL30 significantly decreased the number of PML
NBs per cell. UL30 formed NBs in 40–60% of expressing cells, but
neither PML nor Cajal NB disruption by this protein was
dependent on NB formation. These effects of UL30 may be part of
Figure 5. Disruption of Cajal bodies by CMV UL3 and UL30. (A) UL3- and UL30- expressing U2OS cells and untransfected control cells were
stained with FLAG antibody to detect the viral protein (green) and coilin antibody to detect Cajal bodies (red) and counterstained with DAPI (blue).
Scale bar = 10 mm. (B) Histogram showing the average number of Cajal bodies per cell in cells prepared as in (A). Mean values6SE from 5 separate
experiments are shown. (C) Data from samples in (B) were plotted to show the percentage of cells with a given number of Cajal bodies per cell. Mean
values6SE from 3 separate experiments are shown.
doi:10.1371/journal.ppat.1000100.g005
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that we found to disrupt Cajal bodies also affect PML NBs, the
reverse is not true, as we identified several viral proteins that
disrupted PML NBs but had no noticeable effect on Cajal bodies.
Four viral proteins in addition to UL3 were observed to localize
with and/or alter the morphology of PML NBs to various degrees;
namely CMV US32, UL35 and UL80a and EBV BKRF4. The
most extensive co-localization with PML was seen for US32, an
uncharacterized protein that is not essential for viral replication in
fibroblasts [46]. UL80a functions in capsid assembly and is
homologous to HSV UL26.5 and EBV BDRF1 [51]. UL80a foci
were often juxtaposed to PML NBs although this was not observed
with the UL80a homologues. EBV BKRF4 was found extensively
through the nucleus except for multiple spherical regions from
which it was excluded, and which had PML in the periphery.
BKRF4 has not been functionally characterized but its localization
in the tegument portion of the virion indicates that it could exert
its effects immediately after infection [52].
For CMV UL35 we observed that a high proportion (,50%) of
both 293T and U2OS cells expressing this protein contained
donut-shaped UL35 NBs of various sizes and that all of the visible
PML was associated with the surface or periphery of these
structures. The UL35 gene produces two co-linear proteins at
different times during infection (75 kDa UL35 and 22 Kda
UL35a), which act to regulate transcription from the major
immediate early promoter [53]. Western blots of our UL35-
transfected cells predominantly showed the larger form of the
protein (data not shown), suggesting that UL35 is responsible for
the PML remodeling in our studies. Both UL35 and UL35a can
bind UL82, which is known to associate with PML NBs through
an interaction with hDaxx [54,55]. Previous reports have noted an
association of UL35 with PML NBs in human foreskin fibroblasts,
and found that this association is increased in the presence of
UL82 [54]. Our results extend previous results to show that UL35
can also remodel PML NBs in some cell backgrounds. In our
system co-expression with UL82 did not noticeably alter UL35
localization or PML effects (data not shown).
Our screen of 94 viral proteins with nuclear localization
identified 19 viral proteins that significantly decreased the number
of PML NBs in cells, including several that had not been
previously recognized to do so. Many of these proteins have not
been functionally characterized but their ability to disrupt PML
NBs suggests that they may contribute to viral infection at least in
part by altering host nuclear processes. For tegument proteins or
those expressed early in infection, the disruption of PML NBs may
directly contribute to viral infection. For proteins that are only
present later in infection, the disruption of PML NBs may not be
the contribution of the protein to infection, as PML NBs would
already be disrupted through the action of other proteins.
Nonetheless, the observed PML effects show that these proteins
alter pathways that are linked to PML NBs.
Of the 3 HSV proteins we found to disrupt PML NBs (UL8.5,
UL14, US10), the cellular effects of one (UL14) have been
previously studied. Interestingly, UL14 is a tegument protein that
has been shown to block apoptosis [56]. Since PML NBs are
important for apoptosis, the PML disruption we observed for
UL14 may account for its anti-apoptotic effects. Note that it is also
well established that HSV ICP0 disrupts PML NBs through
degradation of the PML protein [57,58]. While ICP0 was not
included in our initial screen, we did confirm that it disrupted
PML NBs in transfected U2OS cells and had a more dramatic
effect on PML NBs than any of the other viral proteins we tested
(data not shown).
Previously one CMV protein, IE1, was reported to disrupt PML
bodies [59]. While IE1 was not in our screen, we have identified
10 additional CMV proteins with similar effects on PML
disruption, which vary in their degree of importance for infection
[46]. One of the proteins that we found to significantly decrease
Figure 6. Quantification of PML disruption and detection of
SUMOylated viral proteins that cause PML disruption. (A)
Histogram showing the average number of PML bodies per transfected
U2OS cell for each of the indicated viral proteins. Data is presented at
the mean6SE (n=3–8). (B) U2OS cells were co-transfected with the
indicated viral protein and myc-tagged SUMO-1 as indicated, then
subjected to anti-FLAG immunoprecipitation (IP) and Western blotting
(WB) for FLAG (top panel) or SUMO (bottom panel). The SUMO-blot lane
for BFLF2 is from the same blot, exposed for 1/3 the time of the
remaining lanes in order to resolve individual SUMOylated protein
forms. Arrowheads indicate the predicted molecular weight of the
unmodified viral protein. Bands marked with an asterisk (*) represent
higher molecular weight forms of the viral protein that were evident in
the viral protein immunoblot and shown to contain SUMO in the
SUMO-blot.
doi:10.1371/journal.ppat.1000100.g006
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deleted from the AD169 laboratory strain, and hence may
contribute to infection in specific cell backgrounds such as
endothelial cells which are infected by clinical CMV isolates but
not by AD169 [60]. The fact that CMV produces so many
proteins that target PML likely reflects the importance of PML
disruption and PML-related pathways for the CMV replication
and persistence.
The BZLF1 EBV protein has been previously reported to
disrupt PML NBs thereby promoting lytic infection. We also found
BZLF1 to disrupt PML NBs in our assay but identified 5
additional EBV proteins that had a greater effect on PML NBs
than BZLF1 (BDLF1, BFLF2, BLLF2, BRLF1, EBNA3B). Four of
these proteins had predicted sites of SUMOylation and three
(BRLF1, BFLF2 and EBNA3B) were confirmed to be SUMOy-
lated in the transfected U2OS cells. PML must be SUMO-
modified to form NBs, and other SUMO-modified proteins such
as BZLF1 are known to disrupt PML NBs at least in part by
competing for limiting amounts of SUMO thereby inhibiting PML
SUMOylation [17,29]. Therefore it is likely that competition for
SUMO is part of the mechanism by which BRLF1 and EBNA3B
disrupt PML NBs. BRLF1 (also called Rta) has been previously
reported to be SUMOylated at three sites, which contributes to its
ability to activate lytic gene expression [61], however BRLF1 was
not sufficient to disrupt PML NBs when expressed in HeLa
cells [29]. Our results show that BRLF1 is sufficient to disrupt
PML NBs in U2OS cells, indicating that this effect may vary in
different cell backgrounds and suggesting that BRLF1 and BZLF1
might cooperate in promoting lytic activation through PML
disruption.
The finding that EBNA3B disrupts PML NBs was unexpected
as EBNA3B is a latency protein and PML disruption by viral
proteins is generally associated with activation of lytic infection. In
fact EBNA3B is only expressed during latency III or the growth
program in B-cells, which occurs when B lymphocytes are
immortalized with EBV in vitro and in the lymphomas that arise
when patients are immunosuppressed [62,63]. How EBNA3B
contributes to latent infection has not been clearly determined,
although it may be able to regulate viral and cellular transcription
[64,65]. Since PML NBs are important for apoptosis and
negatively affect cancer development [66,67], our results suggest
that EBNA3B may contribute to cell immortalization and/or
malignant transformation by EBV by disrupting PML NBs. PML
disruption by EBNA3B might also be important for counteracting
antiviral responses to latent EBV infection. For example, the EBV
EBER RNA molecules expressed in EBV latency have been shown
to induce the interferon response, which activates expression of the
PML protein [68,69]. However, the number and size of PML NBs
was found to be similar in EBV-positive and EBV-negative B cell
lines [70], suggesting that one or more latency proteins may
counteract the accumulation of PML. EBNA3B is normally
expressed with EBNA3C. Although EBNA3C did not express well
in our assay, it has been previously shown to be modified by
SUMO-3 (but not SUMO-1) and to disrupt PML NBs when
overexpressed [71]. This study also reported detectable levels of
SUMO-3 modification of EBNA3B. However, this appeared to be
less efficient than the extensive modification by SUMO-1 that we
have observed, where EBNA3B was modified at least as efficiently
as the BZLF1 positive control. The similarity in PML disruption
by EBNA3B and EBNA3C suggests that they might act either
redundantly or cooperatively in this role during latency III
infection. It is striking that the functions of several EBV latent and
lytic gene products are regulated by SUMOylation and it seems
likely that this will also hold true for EBNA3B.
In addition to the SUMOylated EBV proteins, two CMV
proteins that we identified as disrupting PML NBs, UL69 and
US25, were shown for the first time to be SUMO-modified. While
US25 has not been functionally characterized, UL69 is a partial
homologue to HSV ICP27 (UL54) and EBV BMLF1 (Table S2)
and is known to have multiple contributions to viral infection,
including transcriptional activation, the export of viral RNA from
the nucleus and induction of cell cycle arrest [72–74]. Our results
suggest that UL69 may also influence viral infection by disruption
of PML NBs and that one or more of the functions of UL69 may
be regulated by SUMOylation. Neither ICP27 nor BMLF1 were
found to disrupt PML NBs, likely reflecting their rather limited
homology with UL69.
Our large-scale screening approach for viral protein localization
has led to the subcellular characterization of 234 proteins, many of
which have not been previously studied. These include 12 proteins
that we showed to be nucleolar and 5 that localize to and/or
remodel PML NBs. In addition we identified 18 proteins that
reduce the number of PML NBs to a greater extent than EBV
BZLF1, which was previously recognized for its ability to disrupt
PML NBs. Strikingly, most of the proteins that localized with and/
or disrupt host NBs are CMV proteins suggesting that this virus is
particularly adept at manipulating host nuclear processes. Our
studies have also shown that disruption of host PML NBs is not a
general phenomenon of viral proteins even when expressed at high
levels, but rather is a property of specific proteins. However, all
three herpesviruses that we tested clearly have multiple mecha-
nisms by which they can disrupt PML NBs, likely reflecting the
importance of this phenomenon and of PML-related pathways for
successful infection. PML NBs have been increasingly tied to key
cellular processes including host defenses, apoptosis, senescence
and DNA repair [17] , and our results provide a starting point for
investigating how the identified viral proteins may affect these
processes through PML disruption.
Materials and Methods
Expression constructs
Expression libraries for HSV-1 (strain 17), CMV (strain AD169)
and EBV (strain B95-8) were generated by PCR amplification of
each predicted open reading frame (ORF), according to the NCBI
entries for each virus, from viral genomic DNA samples generated
as described in [75]. Nineteen additional CMV ORFs (UL133-
151) not present in AD169 were obtained by PCR amplification
from the large Towne strain of CMV. In addition cDNAs for three
spliced EBV ORFs were obtained from Dr. Elliott Kieff (EBNA3B
and EBNA3C) and Dr. George Miller (BZLF1). cDNAs were
inserted into the multicloning site in pMZS3F [32], with the aid of
cloning robots, such that proteins are expressed fused to a C-
terminal sequential purification affinity (SPA) tag comprised of a
calmodulin binding peptide and a triple FLAG epitope.
Immunofluorescence microscopy
Human 293T and U2OS cells were seeded into 6-well
clusterplates on glass coverslips (700,000 cells/well) and transfect-
ed with expression plasmids using Lipofectamine 2000 (Invitrogen)
as per the manufacturer’s instructions, using a DNA to
Lipofectamine 2000 ratio of 2 mg:2 ml for 293T cells and 2 mg:4 ml
for U2OS cells. Transfected cells were fixed 40 h post transfection
with 3.7% formaldehyde in PBS (20 min), permeabilized with
0.5% Triton X-100 in PBS (10 min), and blocked with 4% BSA in
PBS (20 min) prior to incubation with primary and secondary
antibodies in 4% BSA in PBS. Herpesvirus proteins were detected
using either mouse anti-FLAG M2 (Sigma) or rabbit anti-FLAG
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Cajal bodies and ER were visualized using rabbit anti-EBP2 ,
rabbit anti-pan-PML (Chemicon), mouse anti-SC35 (AbCam),
rabbit anti-coilin (Santa Cruz) and mouse anti-PDI (AbCam)
antibodies, respectively. Primary antibodies were detected using
either goat anti-mouse Alexafluor 488 or goat anti-rabbit
Alexafluor 555 secondary antibodies (Molecular Probes). Cover-
slips were mounted onto slides using ProLong Gold antifade
fluorescent mounting medium (Invitrogen) containing DAPI for
visualization of nuclear DNA. Images were acquired using the
636 oil objective (NA 1.4) on a Leica DM IRE2 inverted
fluorescent microscope. Images were processed using OpenLAB
(ver.4.0.2) and Adobe Photoshop version 6.0 using only linear
adjustments.
Quantification of nuclear bodies
Quantification of Cajal and PML bodies was conducted in
U2OS cells prepared as described above for fluorescence
microscopy. For each herpesvirus protein, the number of nuclear
bodies in each of 50 transfected cells was recorded. This data was
used to calculate the average number of PML or Cajal bodies per
transfected cell (histograms) and to quantify the frequency of a
given number of nuclear bodies per cell within a population (line
graphs). Statistical analyses (ANOVA and t-test) were conducted
using GraphPad Prism (version 4.03) software.
SUMOylation assay
U2OS cells in 10 cm plates were co-transfected with 6 mg each
of pMZS3F expressing a viral protein and pCMVmycSUMO1
expressing myc-tagged SUMO-1 (M. MacPherson and P.
Sadowski, in preparation). At 40 h post transfection, cells were
washed twice with PBS and harvested. Cells were lysed with
200 ml lysis buffer (2% SDS, 10% glycerol, 62.5 mM Tris pH 6.8)
plus 1 nM N-ethyl-maleimide (Sigma) and protease inhibitor
cocktail (P8340, Sigma). Samples were boiled for 5 min, sonicated
and clarified by centrifugation at 13,0006 g for 15 min at 4uC.
The viral protein was immunoprecipitated by diluting the samples
to 1 ml with IP buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1%
NP-40) and incubating with anti-FLAG resin (Sigma) for 4 hr at
4uC, with shaking. Beads were washed three times for 30 min in IP
buffer and protein eluted with 50 mlo f2 6protein sample buffer
(5% SDS, 20 mM Tris pH 8, 10% DTT, 20% glycerol). Samples
were subjected to SDS-PAGE, transferred to nitrocellullose
membranes and probed for myc using mouse anti-myc (1:4000
dilution, Abcam) or FLAG using mouse anti-FLAG M2 (1:20,000
dilution, Sigma). 9/10 of each sample was used for the anti-myc
blot to detect SUMO and 1/10 of each sample was used for the
anti-FLAG blot to detect total protein. Bands were detected with
goat anti-mouse HRP (1:5000) and Western Lighting chemilumi-
nescent reagent (PerkinElmer).
Supporting Information
Table S1 Subcellular Localization and PML Disruption Results
for all Herpesvirus Proteins
Found at: doi:10.1371/journal.ppat.1000100.s001 (0.15 MB XLS)
Table S2 293T Cell Localizations of Proteins Conserved in
HSV, CMV and EBV
Found at: doi:10.1371/journal.ppat.1000100.s002 (0.04 MB
DOC)
Table S3 Potential SUMOylation sites in PML-disrupting
Proteins
Found at: doi:10.1371/journal.ppat.1000100.s003 (0.03 MB
DOC)
Figure S1 Size of Herpesvirus Proteins that Alter or Disrupt
PML NBs. Extracts of cell expressing the indicated viral protein
were analyzed by Western blotting using anti-FLAG antibody (A–
C). The predicted molecular weights (MW) for the untagged
proteins are noted below each lane and are not adjusted for the
10 kDa SPA tag. Positions of molecular weight markers are
indicated. Separations between lanes on the gels with the same
MW markers in A and B indicate different exposure times for each
lane from the same gel, to optimize detection of the indicated
protein. Both short and long exposures were included for the
proteins in (C) to show the major bands in the short exposure and
reveal SUMO-modified forms in the longer exposure. UL69 in (C)
was detected on a separate gel. BKRF4, BZLF1, BRLF1 and
UL69 have been previously reported to migrate anomalously
slowly on SDS-PAGE. The majority of proteins that we observed
to migrate slower than their predicted molecular weight are either
highly basic (BLLF2, UL68, TRL9, UL137 and US25) or highly
acidic (BKRF4, BZLF1, UL14, UL98), consistent with the known
property of highly charged proteins to migrate slower than their
molecular weight. Note that variability in protein expression levels
seen in the Western blots is at least partially due to differences in
the percentage of cells expressing each protein (caused by
differences in transfection efficiency of the various plasmids).
Found at: doi:10.1371/journal.ppat.1000100.s004 (4.54 MB TIF)
Figure S2 Herpesvirus Proteins with Subcytoplasmic Localiza-
tions. 293T cells transfected with the indicated viral proteins were
formaldehyde-fixed and stained with FLAG antibody to visualize
the viral protein. Scale bar = 10 mm.
Found at: doi:10.1371/journal.ppat.1000100.s005 (8.52 MB
PNG)
Figure S3 Confirmation of ER Localization. 293T cells were
transfected with the indicated viral proteins with subcytoplasmic
localizations. Cells were fixed and stained with FLAG (red) to
visualize the viral protein and protein disulphide isomerase (PDI,
green) to identify the endoplasmic reticulum. Co-localization is
indicated by yellow in the merged images. CMV US7 is known to
be ER-associated while the localization of BDLF2 is previously
unreported. Scale bar = 10 mm.
Found at: doi:10.1371/journal.ppat.1000100.s006 (3.29 MB TIF)
Figure S4 US1 Alters Nuclear Speckles. Untransfected U2OS
cells (A) and cells transfected with HSV US1 or US1.5 were fixed
and stained for FLAG (red) and SC35 (green) to identify viral
proteins and nuclear speckles respectively. Scale bar = 10 mm.
Found at: doi:10.1371/journal.ppat.1000100.s007 (2.06 MB
PNG)
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